Liabilities / Assets
71st percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
60th percentile
Higher net margin than 60% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
66th percentile
Faster asset growth than 66% of similar nonprofits.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
Up$235,667
Up $20,206 (+9.4%) from 2011
Net Assets
Up$235,667
Up $20,206 (+9.4%) from 2011
Liabilities
Flat$0
Flat from 2011
Revenue And Expenses
Revenue
$191,396
No earlier filing loaded for comparison.
Expenses
Up$171,190
Up $63,819 (+59%) from 2011
Net Income
$20,206
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
To fund medical research for the treatment and public education of adult polyglucosan body disease.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $235,667
- Liabilities
- $0
- Net assets
- $235,667
- Revenue
- $191,396
- Expenses
- $171,190
- Net income
- $20,206